News

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report). The ...
Fintel reports that on April 21, 2025, Guggenheim initiated coverage of Unicycive Therapeutics (NasdaqCM:UNCY) with a Buy ...